4.6
CiteScore
2.2
Impact Factor
- ISSN 1674-8301
- CN 32-1810/R
4.6
2.2
| Citation: |
Jianming Wu, Ling Li. Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications[J]. The Journal of Biomedical Research, 2016, 30(5): 361-372. DOI: 10.7555/JBR.30.20150131
|
| [1] | Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387 |
| [2] | Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Maria Filimonova, Aygul Valiullina, Anna Kudriaeva, Emil Bulatov. Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation[J]. The Journal of Biomedical Research, 2024, 38(6): 531-546. DOI: 10.7555/JBR.38.20240009 |
| [3] | Wenting He, Xiuyu Shi, Zhifang Dong. The roles of RACK1 in the pathogenesis of Alzheimer's disease[J]. The Journal of Biomedical Research, 2024, 38(2): 137-148. DOI: 10.7555/JBR.37.20220259 |
| [4] | Tiwari-Heckler Shilpa, Jiang Z. Gordon, Popov Yury, J. Mukamal Kenneth. Daily high-dose aspirin does not lower APRI in the Aspirin-Myocardial Infarction Study[J]. The Journal of Biomedical Research, 2020, 34(2): 139-142. DOI: 10.7555/JBR.33.20190041 |
| [5] | Huan Liu, Shijiang Zhang, Yongfeng Shao, Xiaohu Lu, Weidong Gu, Buqing Ni, Qun Gu, Junjie Du. Biomechanical characterization of a novel ring connector for sutureless aortic anastomosis[J]. The Journal of Biomedical Research, 2018, 32(6): 454-460. DOI: 10.7555/JBR.31.20170011 |
| [6] | Minbo Zang, Qiao Zhou, Yunfei Zhu, Mingxi Liu, Zuomin Zhou. Effects of chemotherapeutic agent bendamustine for nonhodgkin lymphoma on spermatogenesis in mice[J]. The Journal of Biomedical Research, 2018, 32(6): 442-453. DOI: 10.7555/JBR.31.20170023 |
| [7] | Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065 |
| [8] | Christopher J. Danford, Zemin Yao, Z. Gordon Jiang. Non-alcoholic fatty liver disease: a narrative review of genetics[J]. The Journal of Biomedical Research, 2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045 |
| [9] | Peter Metrakos, Tommy Nilsson. Non-alcoholic fatty liver disease–a chronic disease of the 21st century[J]. The Journal of Biomedical Research, 2018, 32(5): 327-335. DOI: 10.7555/JBR.31.20160153 |
| [10] | Sundeep?S.?Tumber, Hong?Liu. Epidural abscess after multiple lumbar punctures for labour epidural catheter placement[J]. The Journal of Biomedical Research, 2010, 24(4): 332-335. DOI: 10.1016/S1674-8301(10)60046-2 |
| 1. | Friberg S, Lindblad C, Zeiler FA, et al. Fluid biomarkers of chronic traumatic brain injury. Nat Rev Neurol, 2024. DOI:10.1038/s41582-024-01024-z. Online ahead of print |
| 2. | Staabs F, Foverskov Rasmussen H, Buthut M, et al. Brain-targeting autoantibodies in patients with dementia. Front Neurol, 2024, 15: 1412813. DOI:10.3389/fneur.2024.1412813 |
| 3. | Garmendia JV, De Sanctis CV, Das V, et al. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond. Curr Neuropharmacol, 2024, 22(6): 1080-1109. DOI:10.2174/1570159X22666231017141636 |
| 4. | Ehtewish H, Mesleh A, Ponirakis G, et al. Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia. Front Neurol, 2023, 14: 1256745. DOI:10.3389/fneur.2023.1256745 |
| 5. | de Geus MB, Leslie SN, Lam T, et al. Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer's disease in a large clinical sample. Sci Rep, 2023, 13(1): 22406. DOI:10.1038/s41598-023-49440-3 |
| 6. | Marsili L, Marcucci S, LaPorta J, et al. Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment. Biomedicines, 2023, 11(5): 1406. DOI:10.3390/biomedicines11051406 |
| 7. | Rizzo MG, De Plano LM, Palermo N, et al. A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip. Adv Sci (Weinh), 2023, 10(21): e2301650. DOI:10.1002/advs.202301650 |
| 8. | Pingle SC, Lin F, Anekoji MS, et al. Exploring the role of cerebrospinal fluid as analyte in neurologic disorders. Future Sci OA, 2023, 9(4): FSO851. DOI:10.2144/fsoa-2023-0006 |
| 9. | Poppell M, Hammel G, Ren Y. Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases. Int J Mol Sci, 2023, 24(6): 5925. DOI:10.3390/ijms24065925 |
| 10. | Giannoccaro MP, Verde F, Morelli L, et al. Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships. Biomedicines, 2023, 11(3): 666. DOI:10.3390/biomedicines11030666 |
| 11. | Gu D, Wang L, Zhang N, et al. Decrease in naturally occurring antibodies against epitopes of Alzheimer's disease (AD) risk gene products is associated with cognitive decline in AD. J Neuroinflammation, 2023, 20(1): 74. DOI:10.1186/s12974-023-02750-9 |
| 12. | Pocevičiūtė D, Roth B, Schultz N, et al. Plasma IAPP-Autoantibody Levels in Alzheimer's Disease Patients Are Affected by APOE4 Status. Int J Mol Sci, 2023, 24(4): 3776. DOI:10.3390/ijms24043776 |
| 13. | Saavedra J, Nascimento M, Liz MA, et al. Key brain cell interactions and contributions to the pathogenesis of Alzheimer's disease. Front Cell Dev Biol, 2022, 10: 1036123. DOI:10.3389/fcell.2022.1036123 |
| 14. | Sutter PA, Crocker SJ. Glia as antigen-presenting cells in the central nervous system. Curr Opin Neurobiol, 2022, 77: 102646. DOI:10.1016/j.conb.2022.102646 |
| 15. | Stahr N, Galkina EV. Immune Response at the Crossroads of Atherosclerosis and Alzheimer's Disease. Front Cardiovasc Med, 2022, 9: 870144. DOI:10.3389/fcvm.2022.870144 |
| 16. | Zhang X, Zhang X, Gao H, et al. Phage display derived peptides for Alzheimer's disease therapy and diagnosis. Theranostics, 2022, 12(5): 2041-2062. DOI:10.7150/thno.68636 |
| 17. | Morozova A, Zorkina Y, Abramova O, et al. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. Int J Mol Sci, 2022, 23(3): 1217. DOI:10.3390/ijms23031217 |
| 18. | Shim SM, Koh YH, Kim JH, et al. A combination of multiple autoantibodies is associated with the risk of Alzheimer's disease and cognitive impairment. Sci Rep, 2022, 12(1): 1312. DOI:10.1038/s41598-021-04556-2 |
| 19. | Pirovich DB, Da'dara AA, Skelly PJ. Multifunctional Fructose 1, 6-Bisphosphate Aldolase as a Therapeutic Target. Front Mol Biosci, 2021, 8: 719678. DOI:10.3389/fmolb.2021.719678 |
| 20. | Perez DM. Current Developments on the Role of α1-Adrenergic Receptors in Cognition, Cardioprotection, and Metabolism. Front Cell Dev Biol, 2021, 9: 652152. DOI:10.3389/fcell.2021.652152 |
| 21. | Hansen N, Malchow B, Zerr I, et al. Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort. J Neural Transm (Vienna), 2021, 128(3): 357-369. DOI:10.1007/s00702-021-02316-0 |
| 22. | Severini C, Barbato C, Di Certo MG, et al. Alzheimer's Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease. Curr Neuropharmacol, 2021, 19(4): 498-512. DOI:10.2174/1570159X18666200621204546 |
| 23. | Nielsen AK, Folke J, Owczarek S, et al. TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis. Neurol Neuroimmunol Neuroinflamm, 2020, 8(2): e937. DOI:10.1212/NXI.0000000000000937. Print 2021 Mar |
| 24. | Barbé-Tuana F, Funchal G, Schmitz CRR, et al. The interplay between immunosenescence and age-related diseases. Semin Immunopathol, 2020, 42(5): 545-557. DOI:10.1007/s00281-020-00806-z |
| 25. | Sim KY, Im KC, Park SG. The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease. Int J Mol Sci, 2020, 21(15): 5295. DOI:10.3390/ijms21155295 |
| 26. | Jagadeesh A, Maroun LE, Van Es LM, et al. Autoimmune Mechanisms of Interferon Hypersensitivity and Neurodegenerative Diseases: Down Syndrome. Autoimmune Dis, 2020, 2020: 6876920. DOI:10.1155/2020/6876920 |
| 27. | Huang P, Yang YH, Chang YH, et al. Association of early-onset Alzheimer's disease with germline-generated high affinity self-antigen load. Transl Psychiatry, 2020, 10(1): 146. DOI:10.1038/s41398-020-0826-6 |
| 28. | Beutgen VM, Schmelter C, Pfeiffer N, et al. Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire. Clin Transl Immunology, 2020, 9(3): e01101. DOI:10.1002/cti2.1101 |
| 29. | Giannoni P, Claeysen S, Noe F, et al. Peripheral Routes to Neurodegeneration: Passing Through the Blood-Brain Barrier. Front Aging Neurosci, 2020, 12: 3. DOI:10.3389/fnagi.2020.00003 |
| 30. | Yu ZY, Li WW, Yang HM, et al. Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease. Neurotox Res, 2020, 37(4): 1029-1035. DOI:10.1007/s12640-020-00161-9 |
| 31. | Montero-Calle A, San Segundo-Acosta P, Garranzo-Asensio M, et al. The Molecular Misreading of APP and UBB Induces a Humoral Immune Response in Alzheimer's Disease Patients with Diagnostic Ability. Mol Neurobiol, 2020, 57(2): 1009-1020. DOI:10.1007/s12035-019-01809-0 |
| 32. | Lim B, Tsolaki M, Batruch I, et al. Putative autoantibodies in the cerebrospinal fluid of Alzheimer's disease patients. F1000Res, 2019, 8: 1900. DOI:10.12688/f1000research.21140.1 |
| 33. | Behrman S, Lennox B. Autoimmune encephalitis in the elderly: who to test and what to test for. Evid Based Ment Health, 2019, 22(4): 172-176. DOI:10.1136/ebmental-2019-300110 |
| 34. | Giau VV, Bagyinszky E, An SSA. Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment. Int J Mol Sci, 2019, 20(17): 4149. DOI:10.3390/ijms20174149 |
| 35. | Xu ML, Kim HJ, Kim SC, et al. Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening. Oncol Lett, 2019, 18(1): 255-264. DOI:10.3892/ol.2019.10326 |
| 36. | Vegh C, Stokes K, Ma D, et al. A Bird's-Eye View of the Multiple Biochemical Mechanisms that Propel Pathology of Alzheimer's Disease: Recent Advances and Mechanistic Perspectives on How to Halt the Disease Progression Targeting Multiple Pathways. J Alzheimers Dis, 2019, 69(3): 631-649. DOI:10.3233/JAD-181230 |
| 37. | Sim KY, Park SH, Choi KY, et al. High-throughput epitope profiling of antibodies in the plasma of Alzheimer's disease patients using random peptide microarrays. Sci Rep, 2019, 9(1): 4587. DOI:10.1038/s41598-019-40976-x |
| 38. | Tiiman A, Jelić V, Jarvet J, et al. Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis. J Alzheimers Dis, 2019, 68(2): 571-582. DOI:10.3233/JAD-181144 |
| 39. | Sfera A, Gradini R, Cummings M, et al. Rusty Microglia: Trainers of Innate Immunity in Alzheimer's Disease. Front Neurol, 2018, 9: 1062. DOI:10.3389/fneur.2018.01062 |
| 40. | Kotecha AM, Corrêa ADC, Fisher KM, et al. Olfactory Dysfunction as a Global Biomarker for Sniffing out Alzheimer's Disease: A Meta-Analysis. Biosensors (Basel), 2018, 8(2): 41. DOI:10.3390/bios8020041 |
| 41. | Wallukat G, Prüss H, Müller J, et al. Functional autoantibodies in patients with different forms of dementia. PLoS One, 2018, 13(3): e0192778. DOI:10.1371/journal.pone.0192778 |
Supported by: Beijing Renhe Information Technology Co., Ltd. E-mail:
info@rhhz.net 
Authors and Reviewers
DownLoad: